Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-09

Clinical Trial Update: Study of BOTOX Injections in Prevention of Migraine in Adult Participants With Episodic Migraine [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating onabotulinumtoxinA (BOTOX) injections for the prevention of episodic migraine in adults; the study was terminated and results were post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botox (OnabotulinumtoxinA)

Snippet

Sponsor: AbbVie | Conditions: Episodic Migraine | Phase 3 | Status: TERMINATED | Results posted: 2025-12-09